Concord Biotech files DRHP with SEBI for IPO
August 17, 2022
Concord Biotech, the Ahmedabad- grounded turmoil- grounded active pharmaceutical component (API) maker backed by Rare Enterprises and Quadria Capital, filed its Draft Red Herring Prospectus (DRHP) with request controller Securities and Exchange Board of India (SEBI) for an original public immolation (IPO). Sources told that the IPO would be of